FAU.de
Deutsch
Login
Home
Publications
Research Data
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Bayerisches Zentrum für Krebsforschung (BZKF)
Research / Science organisation
Location:
Erlangen, Germany (DE)
Publications
(47)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Correlation of RANK and RANKL with mammographic density in primary breast cancer patients (2024)
Wunderle M, Heindl F, Behrens A, Häberle L, Hack C, Heusinger K, Hübner H, et al.
Journal article
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis (2023)
Munker S, Roessler D, Öcal O, Ben-Khaled N, Bernhart K, Ye L, Piseddu I, et al.
Journal article
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion (2023)
Rejeski K, Perez A, Iacoboni G, Blumenberg V, Bücklein VL, Völkl S, Penack O, et al.
Journal article
Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume Design (2023)
Weissmann T, Mansoorian S, May M, Lettmaier S, Höfler D, Deloch L, Speer S, et al.
Journal article
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance (2023)
Klümper N, Ralser DJ, Ellinger J, Roghmann F, Albrecht J, Below E, Alajati A, et al.
Journal article
Identifying Early Infections in the Setting of CRS with Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL (2023)
Rejeski K, Blumenberg V, Iacoboni G, Lopez-Corral L, Kharboutli S, Hernani R, Petrera A, et al.
Journal article
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial (2023)
Mackensen A, Haanen JB, Koenecke C, Alsdorf W, Wagner-Drouet E, Borchmann P, Heudobler D, et al.
Journal article
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma (2023)
Klümper N, Wüst L, Saal J, Ralser DJ, Zarbl R, Jarczyk J, Breyer J, et al.
Journal article
The future of affordable cancer immunotherapy (2023)
Schaft N, Dörrie J, Schuler G, Schuler-Thurner B, Sallam H, Klein S, Eisenberg G, et al.
Journal article, Review article
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution (2023)
Cox A, Klümper N, Stein J, Sikic D, Breyer J, Bolenz C, Roghmann F, et al.
Journal article
‹
1
2
3
4
5
›